Report Overview
Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
The global Gene Therapy on Neurological Diseases market size was estimated at USD 4347 million in 2023 and is projected to reach USD 16531.47 million by 2032, exhibiting a CAGR of 16.00% during the forecast period.
North America Gene Therapy on Neurological Diseases market size was estimated at USD 1464.69 million in 2023, at a CAGR of 13.71% during the forecast period of 2025 through 2032.
This report provides a deep insight into the global Gene Therapy on Neurological Diseases market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Gene Therapy on Neurological Diseases Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Gene Therapy on Neurological Diseases market in any manner.
Global Gene Therapy on Neurological Diseases Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Biogen
Novartis
Sarepta Therapeutics
Market Segmentation (by Type)
Viral Gene Therapy
Non-viral Gene Therapy
Market Segmentation (by Application)
Hospital
Clinic
Other
Geographic Segmentation
� North America (USA, Canada, Mexico)
� Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
� Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
� South America (Brazil, Argentina, Columbia, Rest of South America)
� The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
� Industry drivers, restraints, and opportunities covered in the study
� Neutral perspective on the market performance
� Recent industry trends and developments
� Competitive landscape & strategies of key players
� Potential & niche segments and regions exhibiting promising growth covered
� Historical, current, and projected market size, in terms of value
� In-depth analysis of the Gene Therapy on Neurological Diseases Market
� Overview of the regional outlook of the Gene Therapy on Neurological Diseases Market:
Key Reasons to Buy this Report:
� Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
� This enables you to anticipate market changes to remain ahead of your competitors
� You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
� The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
� Provision of market value data for each segment and sub-segment
� Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
� Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
� Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
� Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
� The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
� Includes in-depth analysis of the market from various perspectives through Porter�s five forces analysis
� Provides insight into the market through Value Chain
� Market dynamics scenario, along with growth opportunities of the market in the years to come
� 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Gene Therapy on Neurological Diseases Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Gene Therapy on Neurological Diseases, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Gene Therapy on Neurological Diseases
1.2 Key Market Segments
1.2.1 Gene Therapy on Neurological Diseases Segment by Type
1.2.2 Gene Therapy on Neurological Diseases Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Gene Therapy on Neurological Diseases Market Overview
2.1 Global Market Overview
2.1.1 Global Gene Therapy on Neurological Diseases Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Gene Therapy on Neurological Diseases Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Gene Therapy on Neurological Diseases Market Competitive Landscape
3.1 Global Gene Therapy on Neurological Diseases Sales by Manufacturers (2019-2025)
3.2 Global Gene Therapy on Neurological Diseases Revenue Market Share by Manufacturers (2019-2025)
3.3 Gene Therapy on Neurological Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Gene Therapy on Neurological Diseases Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Gene Therapy on Neurological Diseases Sales Sites, Area Served, Product Type
3.6 Gene Therapy on Neurological Diseases Market Competitive Situation and Trends
3.6.1 Gene Therapy on Neurological Diseases Market Concentration Rate
3.6.2 Global 5 and 10 Largest Gene Therapy on Neurological Diseases Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Gene Therapy on Neurological Diseases Industry Chain Analysis
4.1 Gene Therapy on Neurological Diseases Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Gene Therapy on Neurological Diseases Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Gene Therapy on Neurological Diseases Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Gene Therapy on Neurological Diseases Sales Market Share by Type (2019-2025)
6.3 Global Gene Therapy on Neurological Diseases Market Size Market Share by Type (2019-2025)
6.4 Global Gene Therapy on Neurological Diseases Price by Type (2019-2025)
7 Gene Therapy on Neurological Diseases Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Gene Therapy on Neurological Diseases Market Sales by Application (2019-2025)
7.3 Global Gene Therapy on Neurological Diseases Market Size (M USD) by Application (2019-2025)
7.4 Global Gene Therapy on Neurological Diseases Sales Growth Rate by Application (2019-2025)
8 Gene Therapy on Neurological Diseases Market Consumption by Region
8.1 Global Gene Therapy on Neurological Diseases Sales by Region
8.1.1 Global Gene Therapy on Neurological Diseases Sales by Region
8.1.2 Global Gene Therapy on Neurological Diseases Sales Market Share by Region
8.2 North America
8.2.1 North America Gene Therapy on Neurological Diseases Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Gene Therapy on Neurological Diseases Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Gene Therapy on Neurological Diseases Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Gene Therapy on Neurological Diseases Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Gene Therapy on Neurological Diseases Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Gene Therapy on Neurological Diseases Market Production by Region
9.1 Global Production of Gene Therapy on Neurological Diseases by Region (2019-2025)
9.2 Global Gene Therapy on Neurological Diseases Revenue Market Share by Region (2019-2025)
9.3 Global Gene Therapy on Neurological Diseases Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Gene Therapy on Neurological Diseases Production
9.4.1 North America Gene Therapy on Neurological Diseases Production Growth Rate (2019-2025)
9.4.2 North America Gene Therapy on Neurological Diseases Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Gene Therapy on Neurological Diseases Production
9.5.1 Europe Gene Therapy on Neurological Diseases Production Growth Rate (2019-2025)
9.5.2 Europe Gene Therapy on Neurological Diseases Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Gene Therapy on Neurological Diseases Production (2019-2025)
9.6.1 Japan Gene Therapy on Neurological Diseases Production Growth Rate (2019-2025)
9.6.2 Japan Gene Therapy on Neurological Diseases Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Gene Therapy on Neurological Diseases Production (2019-2025)
9.7.1 China Gene Therapy on Neurological Diseases Production Growth Rate (2019-2025)
9.7.2 China Gene Therapy on Neurological Diseases Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Biogen
10.1.1 Biogen Gene Therapy on Neurological Diseases Basic Information
10.1.2 Biogen Gene Therapy on Neurological Diseases Product Overview
10.1.3 Biogen Gene Therapy on Neurological Diseases Product Market Performance
10.1.4 Biogen Business Overview
10.1.5 Biogen Gene Therapy on Neurological Diseases SWOT Analysis
10.1.6 Biogen Recent Developments
10.2 Novartis
10.2.1 Novartis Gene Therapy on Neurological Diseases Basic Information
10.2.2 Novartis Gene Therapy on Neurological Diseases Product Overview
10.2.3 Novartis Gene Therapy on Neurological Diseases Product Market Performance
10.2.4 Novartis Business Overview
10.2.5 Novartis Gene Therapy on Neurological Diseases SWOT Analysis
10.2.6 Novartis Recent Developments
10.3 Sarepta Therapeutics
10.3.1 Sarepta Therapeutics Gene Therapy on Neurological Diseases Basic Information
10.3.2 Sarepta Therapeutics Gene Therapy on Neurological Diseases Product Overview
10.3.3 Sarepta Therapeutics Gene Therapy on Neurological Diseases Product Market Performance
10.3.4 Sarepta Therapeutics Gene Therapy on Neurological Diseases SWOT Analysis
10.3.5 Sarepta Therapeutics Business Overview
10.3.6 Sarepta Therapeutics Recent Developments
11 Gene Therapy on Neurological Diseases Market Forecast by Region
11.1 Global Gene Therapy on Neurological Diseases Market Size Forecast
11.2 Global Gene Therapy on Neurological Diseases Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Gene Therapy on Neurological Diseases Market Size Forecast by Country
11.2.3 Asia Pacific Gene Therapy on Neurological Diseases Market Size Forecast by Region
11.2.4 South America Gene Therapy on Neurological Diseases Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Gene Therapy on Neurological Diseases by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Gene Therapy on Neurological Diseases Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Gene Therapy on Neurological Diseases by Type (2025-2032)
12.1.2 Global Gene Therapy on Neurological Diseases Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Gene Therapy on Neurological Diseases by Type (2025-2032)
12.2 Global Gene Therapy on Neurological Diseases Market Forecast by Application (2025-2032)
12.2.1 Global Gene Therapy on Neurological Diseases Sales (K MT) Forecast by Application
12.2.2 Global Gene Therapy on Neurological Diseases Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Gene Therapy on Neurological Diseases Market Size Comparison by Region (M USD)
Table 5. Global Gene Therapy on Neurological Diseases Sales (K MT) by Manufacturers (2019-2025)
Table 6. Global Gene Therapy on Neurological Diseases Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Gene Therapy on Neurological Diseases Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Gene Therapy on Neurological Diseases Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy on Neurological Diseases as of 2022)
Table 10. Global Market Gene Therapy on Neurological Diseases Average Price (USD/MT) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Gene Therapy on Neurological Diseases Sales Sites and Area Served
Table 12. Manufacturers Gene Therapy on Neurological Diseases Product Type
Table 13. Global Gene Therapy on Neurological Diseases Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Gene Therapy on Neurological Diseases
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Gene Therapy on Neurological Diseases Market Challenges
Table 22. Global Gene Therapy on Neurological Diseases Sales by Type (K MT)
Table 23. Global Gene Therapy on Neurological Diseases Market Size by Type (M USD)
Table 24. Global Gene Therapy on Neurological Diseases Sales (K MT) by Type (2019-2025)
Table 25. Global Gene Therapy on Neurological Diseases Sales Market Share by Type (2019-2025)
Table 26. Global Gene Therapy on Neurological Diseases Market Size (M USD) by Type (2019-2025)
Table 27. Global Gene Therapy on Neurological Diseases Market Size Share by Type (2019-2025)
Table 28. Global Gene Therapy on Neurological Diseases Price (USD/MT) by Type (2019-2025)
Table 29. Global Gene Therapy on Neurological Diseases Sales (K MT) by Application
Table 30. Global Gene Therapy on Neurological Diseases Market Size by Application
Table 31. Global Gene Therapy on Neurological Diseases Sales by Application (2019-2025) & (K MT)
Table 32. Global Gene Therapy on Neurological Diseases Sales Market Share by Application (2019-2025)
Table 33. Global Gene Therapy on Neurological Diseases Sales by Application (2019-2025) & (M USD)
Table 34. Global Gene Therapy on Neurological Diseases Market Share by Application (2019-2025)
Table 35. Global Gene Therapy on Neurological Diseases Sales Growth Rate by Application (2019-2025)
Table 36. Global Gene Therapy on Neurological Diseases Sales by Region (2019-2025) & (K MT)
Table 37. Global Gene Therapy on Neurological Diseases Sales Market Share by Region (2019-2025)
Table 38. North America Gene Therapy on Neurological Diseases Sales by Country (2019-2025) & (K MT)
Table 39. Europe Gene Therapy on Neurological Diseases Sales by Country (2019-2025) & (K MT)
Table 40. Asia Pacific Gene Therapy on Neurological Diseases Sales by Region (2019-2025) & (K MT)
Table 41. South America Gene Therapy on Neurological Diseases Sales by Country (2019-2025) & (K MT)
Table 42. Middle East and Africa Gene Therapy on Neurological Diseases Sales by Region (2019-2025) & (K MT)
Table 43. Global Gene Therapy on Neurological Diseases Production (K MT) by Region (2019-2025)
Table 44. Global Gene Therapy on Neurological Diseases Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Gene Therapy on Neurological Diseases Revenue Market Share by Region (2019-2025)
Table 46. Global Gene Therapy on Neurological Diseases Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 47. North America Gene Therapy on Neurological Diseases Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 48. Europe Gene Therapy on Neurological Diseases Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 49. Japan Gene Therapy on Neurological Diseases Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 50. China Gene Therapy on Neurological Diseases Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 51. Biogen Gene Therapy on Neurological Diseases Basic Information
Table 52. Biogen Gene Therapy on Neurological Diseases Product Overview
Table 53. Biogen Gene Therapy on Neurological Diseases Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 54. Biogen Business Overview
Table 55. Biogen Gene Therapy on Neurological Diseases SWOT Analysis
Table 56. Biogen Recent Developments
Table 57. Novartis Gene Therapy on Neurological Diseases Basic Information
Table 58. Novartis Gene Therapy on Neurological Diseases Product Overview
Table 59. Novartis Gene Therapy on Neurological Diseases Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 60. Novartis Business Overview
Table 61. Novartis Gene Therapy on Neurological Diseases SWOT Analysis
Table 62. Novartis Recent Developments
Table 63. Sarepta Therapeutics Gene Therapy on Neurological Diseases Basic Information
Table 64. Sarepta Therapeutics Gene Therapy on Neurological Diseases Product Overview
Table 65. Sarepta Therapeutics Gene Therapy on Neurological Diseases Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 66. Sarepta Therapeutics Gene Therapy on Neurological Diseases SWOT Analysis
Table 67. Sarepta Therapeutics Business Overview
Table 68. Sarepta Therapeutics Recent Developments
Table 69. Global Gene Therapy on Neurological Diseases Sales Forecast by Region (2025-2032) & (K MT)
Table 70. Global Gene Therapy on Neurological Diseases Market Size Forecast by Region (2025-2032) & (M USD)
Table 71. North America Gene Therapy on Neurological Diseases Sales Forecast by Country (2025-2032) & (K MT)
Table 72. North America Gene Therapy on Neurological Diseases Market Size Forecast by Country (2025-2032) & (M USD)
Table 73. Europe Gene Therapy on Neurological Diseases Sales Forecast by Country (2025-2032) & (K MT)
Table 74. Europe Gene Therapy on Neurological Diseases Market Size Forecast by Country (2025-2032) & (M USD)
Table 75. Asia Pacific Gene Therapy on Neurological Diseases Sales Forecast by Region (2025-2032) & (K MT)
Table 76. Asia Pacific Gene Therapy on Neurological Diseases Market Size Forecast by Region (2025-2032) & (M USD)
Table 77. South America Gene Therapy on Neurological Diseases Sales Forecast by Country (2025-2032) & (K MT)
Table 78. South America Gene Therapy on Neurological Diseases Market Size Forecast by Country (2025-2032) & (M USD)
Table 79. Middle East and Africa Gene Therapy on Neurological Diseases Consumption Forecast by Country (2025-2032) & (Units)
Table 80. Middle East and Africa Gene Therapy on Neurological Diseases Market Size Forecast by Country (2025-2032) & (M USD)
Table 81. Global Gene Therapy on Neurological Diseases Sales Forecast by Type (2025-2032) & (K MT)
Table 82. Global Gene Therapy on Neurological Diseases Market Size Forecast by Type (2025-2032) & (M USD)
Table 83. Global Gene Therapy on Neurological Diseases Price Forecast by Type (2025-2032) & (USD/MT)
Table 84. Global Gene Therapy on Neurological Diseases Sales (K MT) Forecast by Application (2025-2032)
Table 85. Global Gene Therapy on Neurological Diseases Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Gene Therapy on Neurological Diseases
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Gene Therapy on Neurological Diseases Market Size (M USD), 2019-2032
Figure 5. Global Gene Therapy on Neurological Diseases Market Size (M USD) (2019-2032)
Figure 6. Global Gene Therapy on Neurological Diseases Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Gene Therapy on Neurological Diseases Market Size by Country (M USD)
Figure 11. Gene Therapy on Neurological Diseases Sales Share by Manufacturers in 2023
Figure 12. Global Gene Therapy on Neurological Diseases Revenue Share by Manufacturers in 2023
Figure 13. Gene Therapy on Neurological Diseases Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Gene Therapy on Neurological Diseases Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Gene Therapy on Neurological Diseases Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Gene Therapy on Neurological Diseases Market Share by Type
Figure 18. Sales Market Share of Gene Therapy on Neurological Diseases by Type (2019-2025)
Figure 19. Sales Market Share of Gene Therapy on Neurological Diseases by Type in 2023
Figure 20. Market Size Share of Gene Therapy on Neurological Diseases by Type (2019-2025)
Figure 21. Market Size Market Share of Gene Therapy on Neurological Diseases by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Gene Therapy on Neurological Diseases Market Share by Application
Figure 24. Global Gene Therapy on Neurological Diseases Sales Market Share by Application (2019-2025)
Figure 25. Global Gene Therapy on Neurological Diseases Sales Market Share by Application in 2023
Figure 26. Global Gene Therapy on Neurological Diseases Market Share by Application (2019-2025)
Figure 27. Global Gene Therapy on Neurological Diseases Market Share by Application in 2023
Figure 28. Global Gene Therapy on Neurological Diseases Sales Growth Rate by Application (2019-2025)
Figure 29. Global Gene Therapy on Neurological Diseases Sales Market Share by Region (2019-2025)
Figure 30. North America Gene Therapy on Neurological Diseases Sales and Growth Rate (2019-2025) & (K MT)
Figure 31. North America Gene Therapy on Neurological Diseases Sales Market Share by Country in 2023
Figure 32. U.S. Gene Therapy on Neurological Diseases Sales and Growth Rate (2019-2025) & (K MT)
Figure 33. Canada Gene Therapy on Neurological Diseases Sales (K MT) and Growth Rate (2019-2025)
Figure 34. Mexico Gene Therapy on Neurological Diseases Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Gene Therapy on Neurological Diseases Sales and Growth Rate (2019-2025) & (K MT)
Figure 36. Europe Gene Therapy on Neurological Diseases Sales Market Share by Country in 2023
Figure 37. Germany Gene Therapy on Neurological Diseases Sales and Growth Rate (2019-2025) & (K MT)
Figure 38. France Gene Therapy on Neurological Diseases Sales and Growth Rate (2019-2025) & (K MT)
Figure 39. U.K. Gene Therapy on Neurological Diseases Sales and Growth Rate (2019-2025) & (K MT)
Figure 40. Italy Gene Therapy on Neurological Diseases Sales and Growth Rate (2019-2025) & (K MT)
Figure 41. Russia Gene Therapy on Neurological Diseases Sales and Growth Rate (2019-2025) & (K MT)
Figure 42. Asia Pacific Gene Therapy on Neurological Diseases Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Gene Therapy on Neurological Diseases Sales Market Share by Region in 2023
Figure 44. China Gene Therapy on Neurological Diseases Sales and Growth Rate (2019-2025) & (K MT)
Figure 45. Japan Gene Therapy on Neurological Diseases Sales and Growth Rate (2019-2025) & (K MT)
Figure 46. South Korea Gene Therapy on Neurological Diseases Sales and Growth Rate (2019-2025) & (K MT)
Figure 47. India Gene Therapy on Neurological Diseases Sales and Growth Rate (2019-2025) & (K MT)
Figure 48. Southeast Asia Gene Therapy on Neurological Diseases Sales and Growth Rate (2019-2025) & (K MT)
Figure 49. South America Gene Therapy on Neurological Diseases Sales and Growth Rate (K MT)
Figure 50. South America Gene Therapy on Neurological Diseases Sales Market Share by Country in 2023
Figure 51. Brazil Gene Therapy on Neurological Diseases Sales and Growth Rate (2019-2025) & (K MT)
Figure 52. Argentina Gene Therapy on Neurological Diseases Sales and Growth Rate (2019-2025) & (K MT)
Figure 53. Columbia Gene Therapy on Neurological Diseases Sales and Growth Rate (2019-2025) & (K MT)
Figure 54. Middle East and Africa Gene Therapy on Neurological Diseases Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Gene Therapy on Neurological Diseases Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Gene Therapy on Neurological Diseases Sales and Growth Rate (2019-2025) & (K MT)
Figure 57. UAE Gene Therapy on Neurological Diseases Sales and Growth Rate (2019-2025) & (K MT)
Figure 58. Egypt Gene Therapy on Neurological Diseases Sales and Growth Rate (2019-2025) & (K MT)
Figure 59. Nigeria Gene Therapy on Neurological Diseases Sales and Growth Rate (2019-2025) & (K MT)
Figure 60. South Africa Gene Therapy on Neurological Diseases Sales and Growth Rate (2019-2025) & (K MT)
Figure 61. Global Gene Therapy on Neurological Diseases Production Market Share by Region (2019-2025)
Figure 62. North America Gene Therapy on Neurological Diseases Production (K MT) Growth Rate (2019-2025)
Figure 63. Europe Gene Therapy on Neurological Diseases Production (K MT) Growth Rate (2019-2025)
Figure 64. Japan Gene Therapy on Neurological Diseases Production (K MT) Growth Rate (2019-2025)
Figure 65. China Gene Therapy on Neurological Diseases Production (K MT) Growth Rate (2019-2025)
Figure 66. Global Gene Therapy on Neurological Diseases Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Gene Therapy on Neurological Diseases Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Gene Therapy on Neurological Diseases Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Gene Therapy on Neurological Diseases Market Share Forecast by Type (2025-2032)
Figure 70. Global Gene Therapy on Neurological Diseases Sales Forecast by Application (2025-2032)
Figure 71. Global Gene Therapy on Neurological Diseases Market Share Forecast by Application (2025-2032)
